Bharat Biotech, developer of indigenous COVID-19 vaccine, COVAXIN has applied to the central drug regulator, DCGI, seeking emergency use authorization for its vaccine.... Dec 08
Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
Cynata Therapeutics announces that the Phase 3 Osteoarthritis Clinical Trial..... Nov 12
Vir Biotechnology, Inc. and GlaxoSmithKline today announced the global expansion to Phase 3 of the COMET-ICE study for the early treatment of COVID-19 ... Oct 06
Sanofi and GSK finalised and signed today an advanced purchase agreement with the European Commission (EC) for supplying their vaccine... Sep 20
The vaccine will be administered without proper safety levels verified... Sep 11
The rheumatoid arthritis drug Kevzara from Sanofi fails Covid clinical trials... Sep 02
Phase 3 Trial demonstrates statistically significant faster time to clinical improvement with Favipiravir treatment in mild to moderate COVID 19 patients... Jul 23
China is seeking to trial potential vaccines overseas because of a lack of new patients at home.... Jun 24
2,50,087 Indian nationals stranded abroad have been repatriated since the beginning of Vande Bharat Mission last month.... Jun 22
Gilead wins approval for Remdesivir in India after phase 3 trial results are announced... Jun 02
GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease. ... Jan 16
-Advertisements-
.jpeg)
Friday, July 31, 2026
.jpg)
.jpg)
.jpg)
.jpeg)
.jpg)
.jpg)
.jpg)
